Parkside Financial Bank & Trust’s Cidara Therapeutics CDTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$2.43K	–	2703
2025 Q4	$2.43K	Buy	+11	New	+$1.78K	﹤0.01%	2037

Parkside Financial Bank & Trust's CDTX Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 11 shares — an estimated $2.43K sold.

Parkside Financial Bank & Trust first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $2.43K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Parkside Financial Bank & Trust reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 11 Cidara Therapeutics shares in Q1 2026, an estimated $2.43K.
Parkside Financial Bank & Trust first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Parkside Financial Bank & Trust's Cidara Therapeutics position peaked at $2.43K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.